Skip to main content

Featured

Canada Groceries and Essentials Benefit: What You Need to Know About Tomorrow's Payment

  If you've ever received a GST/HST credit payment from the CRA, there's a good chance money is landing in your bank account tomorrow — and this time, it could be noticeably bigger than usual. On June 5, 2026 , the federal government is issuing a one-time top-up payment to more than 12 million eligible Canadians as part of the transition to the new Canada Groceries and Essentials Benefit (CGEB) . Here's what the payment is, how much you could receive, and what changes are coming in July. What Is the June 5 Payment? The June 5 deposit is a one-time GST/HST credit top-up — equal to 50% of your annual GST/HST credit entitlement for the 2025–26 benefit year. Think of it as a bonus mid-year payment on top of your regular quarterly schedule. This payment is part of the federal government's bridge between the old GST/HST credit and the new Canada Groceries and Essentials Benefit, which officially launches in July 2026. The goal is to get money into Canadians' hands now, b...
Post a Comment
Read more

article

Labels

Revolutionary Gene Therapy Restores Hearing in Deaf Toddler

 

In a remarkable medical breakthrough, an 18-month-old toddler named Opal Sandy has regained her hearing thanks to a pioneering gene therapy trial. Born deaf due to a rare genetic condition affecting the OTOF gene, which is responsible for producing a protein essential for hearing, Opal’s prospects for natural hearing were bleak. However, the innovative treatment at Cambridge University Hospitals in England has opened up a world of sound for her.

The procedure involved the infusion of a working copy of the OTOF gene into Opal’s right ear, a process that took a mere 16 minutes. Remarkably, within weeks, Opal began responding to loud noises, and after 24 weeks, she could hear whispers, indicating a near-normal level of hearing restoration.

Opal’s case is part of the Chord trial, which is recruiting more children from the UK, Spain, and the US to undergo similar treatment. The trial is being closely monitored, with participants followed up for five years to assess the long-term efficacy and safety of the therapy.

The success of this gene therapy is a beacon of hope for many suffering from genetic deafness, signaling the dawn of a new era in medical science where conditions once thought incurable are now within the realm of treatment. Opal’s story is not just a personal victory; it’s a milestone in genetic medicine, showcasing the incredible potential of gene therapy to change lives.

Labels:

Comments

Post a Comment